文献速递食管胃疾病与幽门螺杆菌胃肠动力与功能性疾病消化内镜

根据经验性抑酸试验失败后典型症状表型优化胃食管反流的成本效益评估

Optimizing the Cost-Effective Evaluation of Gastroesophageal Reflux by Typical Symptom Phenotypes After Failure of Empiric Acid Suppression Trial.
PubMed 文献 · Am J Gastroenterol · 2025-06-05

该研究建立决策分析模型,评估经验性质子泵抑制剂(PPI)治疗失败后持续症状患者按主要典型症状(烧心、反流、胸痛)选择胃食管反流病(GERD)诊断策略的成本效益。结果显示,一线门诊反流检测较单独内镜可节省2500至4500美元;烧心和胸痛患者首选96小时无线pH监测,反流患者首选24小时pH-阻抗监测,两者均在停用PPI状态下进行;对于有GERD证据且PPI难治症状者,加做PPI治疗下pH-阻抗监测可优化成本效益。基于Lyon 2.0按症状表型定制诊断策略较一刀切策略更优。

要点

  • 经验性PPI失败后持续典型症状患者,一线门诊反流检测较单独内镜节省2500至4500美元。
  • 烧心或胸痛患者最具成本效益的初始检测为停药PPI下96小时无线pH监测。
  • 反流患者最具成本效益的初始检测为停药PPI下24小时pH-阻抗监测。

核心结论

  • 与一刀切策略相比,基于Lyon 2.0按主要症状表型定制诊断可优化GERD的成本效益评估与管理。

研究设计与样本

  • 决策分析模型,评估PPI优化或停用经验性试验、上消化道内镜、无线pH监测和pH-阻抗监测的所有组合。
  • 模型应用于普通消化内科烧心、反流和胸痛患者,从支付方和患者角度确定合适的检测组合与顺序。
  • 健康结局来自临床试验的系统综述,成本结局来自美国医疗保险和医疗补助服务中心及商业数据集和国家观察性研究。
  • 时间跨度为1年,支付意愿阈值为每获得1个质量调整生命年10万美元。

主要发现

  • 经验性PPI失败后持续典型GERD症状患者,未发现糜烂性食管炎时,一线门诊反流检测较单独内镜节省2500至4500美元。
  • 烧心和胸痛患者最具成本效益的初始门诊反流检测为停药PPI下96小时无线pH监测。
  • 反流患者最具成本效益的初始门诊反流检测为停药PPI下24小时pH-阻抗监测。
  • 对于有GERD证据且PPI难治症状的患者,加做PPI治疗下pH-阻抗监测可优化成本效益。
  • 患者和支付方角度在这些最优诊断策略上一致。

临床怎么用

  • 经验性PPI失败后持续典型症状患者,可考虑一线门诊反流检测而非单独内镜以节省成本。
  • 烧心或胸痛患者可考虑停药PPI下96小时无线pH监测作为初始检测。
  • 反流患者可考虑停药PPI下24小时pH-阻抗监测作为初始检测。
  • 有GERD证据且PPI难治症状的患者可考虑加做PPI治疗下pH-阻抗监测。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Concern for gastroesophageal reflux disease (GERD) is the most common reason to consult gastroenterology. We aimed to optimize routine GERD evaluation on cost-effectiveness according to the dominant typical symptom among patients with persistent symptoms failing empiric proton-pump inhibitors (PPI). METHODS: We developed a decision analytic model evaluating all permutations of GERD diagnostics including empiric trials of PPI optimization or discontinuation, upper endoscopy, wireless pH-monitoring, and pH-impedance monitoring. The model was applied to patients with heartburn, regurgitation, and chest pain in general gastroenterology to identify the appropriate combination and order of testing from insurer and patient perspectives. Health outcomes were informed by systematic reviews of clinical trials. Cost outcomes were informed by Centers for Medicare and Medicaid Services and commercial datasets and national observational studies. The time horizon was 1 year, and willingness-to-pay threshold was $100,000/quality-adjusted life year gained. RESULTS: For patients with typical persistent GERD symptoms failing empiric PPI, routine up-front ambulatory reflux testing saved $2,500-$4,500 compared with endoscopy alone when no erosive esophagitis is found. The most cost-effective initial ambulatory reflux test was 96-hour wireless pH-monitoring for patients with heartburn and chest pain and 24-hour pH-impedance monitoring for patients with regurgitation, both performed OFF-PPI. Adding ON-PPI pH-impedance monitoring optimized cost-effectiveness for patients with documented evidence of GERD and PPI-refractory symptoms. Patient and insurer perspectives aligned on these optimal diagnostic strategies. DISCUSSION: Compared with a one-size-fits-all strategy, a tailored approach based on Lyon 2.0 optimizes cost-effective evaluation and management of GERD by phenotyping the appropriate diagnostics to dominant symptom.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Shah ED, Gyawali CP, Chan WW, et al. Optimizing the Cost-Effective Evaluation of Gastroesophageal Reflux by Typical Symptom Phenotypes After Failure of Empiric Acid Suppression Trial. Am J Gastroenterol. 2025. PMID: 40471840. doi:10.14309/ajg.0000000000003576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。